M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating

Completed

Conditions: Lung Cancer

Interventions: Procedure: PET/CT Scan

First Posted Date: 2009-02-13

Last Posted Date: 2016-02-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 12

Registration Number: NCT00843219

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Interview

First Posted Date: 2009-02-06

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 26

Registration Number: NCT00838318

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System

Completed

Conditions: Ovarian Cancer

First Posted Date: 2009-02-06

Last Posted Date: 2012-12-21

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 241

Registration Number: NCT00837993

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Huachansu & Gemcitabine in Pancreatic Cancer

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: HuaChanSu
Drug: Placebo

First Posted Date: 2009-02-05

Last Posted Date: 2012-07-12

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 80

Registration Number: NCT00837239

Locations: 🇨🇳
Cancer Hospital Fudan University, Shanghai, China

Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2009-02-05

Last Posted Date: 2021-05-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 938

Registration Number: NCT00837499

Locations: 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
The Rose Diagnostic Center, Houston, Texas, United States

and more 4 locations

Questionnaire and Fall Risk Assessment

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Interview
Other: Physical Function Tests

First Posted Date: 2009-02-04

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 34

Registration Number: NCT00836238

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver

Phase 1

Completed

Conditions: Liver Metastasis
Melanoma

Interventions: Drug: Nab-Paclitaxel (Abraxane)

First Posted Date: 2009-02-02

Last Posted Date: 2015-11-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT00833807

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

FDG-PET-CT and Biomarkers in Esophageal Cancer

Not Applicable

Completed

Conditions: Gastrointestinal Disease
Esophageal Cancer

Interventions: Procedure: PET/CT (FDG PET/CT)
Other: Biomarker Testings

First Posted Date: 2009-02-02

Last Posted Date: 2016-10-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 31

Registration Number: NCT00833625

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Phase 2

Active, not recruiting

Conditions: Eyelid Sebaceous Gland Carcinoma

Interventions: Procedure: Lymph Node Mapping
Procedure: Sentinel Lymph Node Biopsy
Drug: Technetium Tc-99m Sulfur Colloid

First Posted Date: 2009-01-30

Last Posted Date: 2024-06-10

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 20

Registration Number: NCT00832429

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)

Phase 1

Completed

Conditions: Lung Cancer

Interventions: Procedure: EBUS-TBNA

First Posted Date: 2009-01-30

Last Posted Date: 2016-07-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 120

Registration Number: NCT00832715

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy